Generative Active Learning for the Search of Small-molecule Protein Binders
Authors:
Maksym Korablyov,
Cheng-Hao Liu,
Moksh Jain,
Almer M. van der Sloot,
Eric Jolicoeur,
Edward Ruediger,
Andrei Cristian Nica,
Emmanuel Bengio,
Kostiantyn Lapchevskyi,
Daniel St-Cyr,
Doris Alexandra Schuetz,
Victor Ion Butoi,
Jarrid Rector-Brooks,
Simon Blackburn,
Leo Feng,
Hadi Nekoei,
SaiKrishna Gottipati,
Priyesh Vijayan,
Prateek Gupta,
Ladislav Rampášek,
Sasikanth Avancha,
Pierre-Luc Bacon,
William L. Hamilton,
Brooks Paige,
Sanchit Misra
, et al. (9 additional authors not shown)
Abstract:
Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. Powered by deep reinforcement learning, LambdaZero learns to search over the vast space of molecu…
▽ More
Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. Powered by deep reinforcement learning, LambdaZero learns to search over the vast space of molecules to discover candidates with a desired property. We apply LambdaZero with molecular docking to design novel small molecules that inhibit the enzyme soluble Epoxide Hydrolase 2 (sEH), while enforcing constraints on synthesizability and drug-likeliness. LambdaZero provides an exponential speedup in terms of the number of calls to the expensive molecular docking oracle, and LambdaZero de novo designed molecules reach docking scores that would otherwise require the virtual screening of a hundred billion molecules. Importantly, LambdaZero discovers novel scaffolds of synthesizable, drug-like inhibitors for sEH. In in vitro experimental validation, a series of ligands from a generated quinazoline-based scaffold were synthesized, and the lead inhibitor N-(4,6-di(pyrrolidin-1-yl)quinazolin-2-yl)-N-methylbenzamide (UM0152893) displayed sub-micromolar enzyme inhibition of sEH.
△ Less
Submitted 2 May, 2024;
originally announced May 2024.
SE(3)-Stochastic Flow Matching for Protein Backbone Generation
Authors:
Avishek Joey Bose,
Tara Akhound-Sadegh,
Guillaume Huguet,
Kilian Fatras,
Jarrid Rector-Brooks,
Cheng-Hao Liu,
Andrei Cristian Nica,
Maksym Korablyov,
Michael Bronstein,
Alexander Tong
Abstract:
The computational design of novel protein structures has the potential to impact numerous scientific disciplines greatly. Toward this goal, we introduce FoldFlow, a series of novel generative models of increasing modeling power based on the flow-matching paradigm over $3\mathrm{D}$ rigid motions -- i.e. the group $\text{SE}(3)$ -- enabling accurate modeling of protein backbones. We first introduce…
▽ More
The computational design of novel protein structures has the potential to impact numerous scientific disciplines greatly. Toward this goal, we introduce FoldFlow, a series of novel generative models of increasing modeling power based on the flow-matching paradigm over $3\mathrm{D}$ rigid motions -- i.e. the group $\text{SE}(3)$ -- enabling accurate modeling of protein backbones. We first introduce FoldFlow-Base, a simulation-free approach to learning deterministic continuous-time dynamics and matching invariant target distributions on $\text{SE}(3)$. We next accelerate training by incorporating Riemannian optimal transport to create FoldFlow-OT, leading to the construction of both more simple and stable flows. Finally, we design FoldFlow-SFM, coupling both Riemannian OT and simulation-free training to learn stochastic continuous-time dynamics over $\text{SE}(3)$. Our family of FoldFlow, generative models offers several key advantages over previous approaches to the generative modeling of proteins: they are more stable and faster to train than diffusion-based approaches, and our models enjoy the ability to map any invariant source distribution to any invariant target distribution over $\text{SE}(3)$. Empirically, we validate FoldFlow, on protein backbone generation of up to $300$ amino acids leading to high-quality designable, diverse, and novel samples.
△ Less
Submitted 11 April, 2024; v1 submitted 3 October, 2023;
originally announced October 2023.
